Clarification on the news article by internet media on Jun 21,2019

Date of occurrence of the event: Jun 21, 2019 Company name: OBI Pharma, Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: None Name of mass media: Internet media Content reported: “The application for OBI-822 clinical studies in China is delayed by 2 years, which requires supplementation for […]